Powered by

Five things for pharma marketers to know: Tuesday, March 14, 2017

Mar 20, 2017 - Medical Marketing & Media (MMM)

1. Pershing Square Capital Management sold its entire stake in Valeant Pharmaceutical Industries. That firm lost about $4 billion in two years as a result of its stake in the drugmaker. ( NYT )

2. Novartis received FDA approval to market a combination of its experimental drug kisqali and letrozole to treat breast cancer in postmenopausal women as a first-line treatment. More than half of patients achieved progression-free survival in a late-stage trial. ( Reuters )

3. Express Scripts

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox